A well tolerated oral combination of chlorambucil (Leukeran R), methotrexate, fluorouracil, prednisone (LMFP) in disseminated breast cancer.
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000628:therapy; D002699:Chlorambucil / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage
D000970:Antineoplastic Agents; D002699:Chlorambucil; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate